News Releases

NOTICE TO HOSPITALS Health Canada Endorsed Important Safety Information on YERVOY 200 mg/40 mL(5 mg/mL) (Ipilimumab for injection), single-use vial

Categories: Notice to hospitals | Public Notices | Yervoy

Subject: Recall of YERVOY (ipilimumab for injection) 200 mg/40 mL vial DIN 02379384 – Lots 924741 and 924041


Dear Healthcare Professional:

Please distribute to relevant Departments of Pharmacy, Oncology, Oncology clinics, Internal Medicine, Nursing, and other Departments as required, and other involved professional staff and post this notice in your institution.

2014-10-18 Yervoy_E_Notice.pdf

Back to News Releases